February 8-10, 2008 Ft. Lauderdale, FL

Transcription

1 PRI-MED SYMPOSIA Pri-Med South CONFERENCE & EXHIBITION February 8-10, 2008 Ft. Lauderdale, FL Earn up to 17 AMA PRA Category 1 Credit(s)

2 Pre-Conference Symposia Day Schedule Thursday, February 7, :30 AM 7:30 AM Registration & Breakfast 7:30 AM 7:45 AM Opening Remarks 7:45 AM 9:00 AM Benefit to Risk Ratios for Treatment of Type 2 Diabetes 9:15 AM 10:30 AM Implementing and Monitoring Treatment in Chronic Pain: Improving Symptoms and Quality of Life 10:45 AM 12:00 PM Inhibiting the Renin Angiotensin System (RAS) in High Risk Patients: Can We Do Better? 12:30 PM 1:45 PM Adult ADHD: When Comorbidities Are the Tip of the Iceberg 2:00 PM 3:15 PM Using Combination Therapy to Improve Atherogenic Lipid Abnormalities and Reduce Residual Cardiovascular Risk 3:30 PM 4:45 PM Continuum of Care: Thyroid Disease from the Clinic to the Pharmacy *Titles are subject to change PRE-CONFERENCE SYMPOSIA DAY ACCREDITATION STATEMENT Pri-Med institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. DESIGNATION STATEMENT Pri-Med designates this educational activity for a maximum of 7.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. AAFP APPLICATION Application for CME credit has been filed with the American Academy of family Physicians. Determination of credit is pending. AANP ACCREDITATION Pri-Med institute is approved as a provider of nurse practitioner continuing education by the American Academy of nurse Practitioners. AANP provider This program has been approved for 7.5 contact hours of continuing education (which includes 3.75 hours of pharmacology). AMERICAN WITH DISABILATIES STATEMENT In accordance with the Americans with Disabilities Act, Pri-Med institute seeks to make this conference accessible to all. if you have a need which might require special accommodations, please call 877-4PRI-MED or support@pri-med.com three weeks prior to the meeting. COMMERCIAL SUPPORT These CME activities are supported by educational grants from GlaxoSmithKline, Abbott, Novartis Pharmaceuticals Corporation, Shire Pharmaceuticals Inc., Abbott Laboratories of all Pre Conference Symposia - Track 1. INDUSTRY-SUPPORTED SYMPOSIA ACCREDITATION Symposia are produced independently of Harvard Medical School and Leonard M. Miller School of Medicine at the University of Miami. Sessions are planned and produced in accordance with the Accreditation Council for Continuing Medical Education. To obtain credit for industry-supported Symposia, you will need to scan your Attendance ScanCard at each symposium attended. Credit certificates will either be distributed at the conclusion of the symposium or mailed to you by the accrediting institution approximately eight weeks after the close of the conference.

3 Lunch Symposia Friday, February 8, :00 PM -1:30 PM A Practical Guide to Post ACS Antithrombotic Therapy Amit Khera, MD,MSc,FACC Assistant Professor, Internal Medicine: Cardiology Division of Cardiology Director, Program in Preventive Cardiology University of Texas Southwestern Medical School Dallas, TX Manu Rajachandran, MD,FACC,FSCAI Chairman, Department of Endovascular Medicine Director, Comprehensive Vascular Program Clinical Associate Professor of Medicine UMDNJ Robert Wood Johnson Medical School New Brunswick, NJ Outline key elements of the 2007 Updated ACC/AHA Guidelines for the Management of STEMI and UA/NSTEMI relating to long term management of the post ACS patient to prevent secondary events and reduce morbidity and mortality Identify three adherence strategies that improve the role of dual antiplatelet therapy in preventing MI and death in patients post stenting Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from Bristol-Myers Squibb/sanofi-aventis..

4 Lunch Symposia Friday, February 8, :00 PM -1:30 PM Differentiating Leg Disorders: Understanding Impact and Improving Patient Outcomes Richard P Allen, PhD Assistant Professor Department of Neurology Research Associate The Johns Hopkins University School of Medicine Baltimore, MD N. Lawrence Edwards, MD Professor of Medicine Vice Chairman Department of Medicine University of Florida Gainesville, FL Kambhampaty V Krishnasastry, MD Chief Clinical Associate Professor Division of Vascular & Endovascular Surgery North Shore University Hospital Manhasset, NY Categorize leg disorders that are neurological, musculoskeletal, or cardiovascular in nature Distinguish the pathophysiology of highly prevalent leg disorders Discuss a rationale for treatment strategies that improve patient outcomes Accreditation Statement: Professional Postgraduate Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Professional Postgraduate Services designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from AR Scientific, Inc.

5 Dinner Symposia Friday, February 8, :00 PM -1:30 PM Demystifying Fibromyalgia - A Primary Care Primer Daniel J Clauw, MD Professor of Medicine Division of Rheumatology Director Chronic Pain and Fatigue Research Center University of Michigan Medical Center Ann Arbor, MI Kurt Kroenke, MD Professor of Medicine/Director of Fellowship Training Programs and Research Scientist Regenstrief Institute Indiana University School of Medicine Indianapolis, IN Philip J Mease, MD Clinical Professor Chief, Rheumatology Clinical Research Swedish Hospital Medical Center University of Washington Seattle, WA Explain the ACR classification criteria to confirm a FMS diagnosis, with emphasis on positive and negative implications of the criteria Defend or challenge current perceptions regarding etiology and pathophysiology of FMS List the components of musculoskeletal/neurologic examination that differentiate from other sources of pain Summarize individual and combined therapies available to patients, from cognitive or operant behavior modification techniques and physical therapy to pharmacotherapy Identify up to date data on novel pharmacotherapies being evaluated for use in FMS Accreditation Statement: This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical education through the joint sponsorship of the Duke University School of Medicine and Context healthcare Group. Designation Statement: The Duke University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from the Forest Research Institute.

6 Dinner Symposia Friday, February 8, :00 PM -1:30 PM RAPID: Rheumatoid Arthritis: Primary Care Initiative for Improved Diagnosis and Outcomes Louis Kuritzky, MD Clinical Assistant Professor Department of Community Health and Family Medicine Family Medicine Residency Program University of Florida Gainesville, FL Joseph A. Markenson, MD Attending Chairperson Special Surgery NY Presbyterian Hospital New York, NY Have increased knowledge regarding: a. The early aggressive nature of joint damage in RA b. The optimal management of through early diagnosis and aggressive initiation of disease modifying antirhuematic drug (DMARD) therapy c. The risks and benefits of the therapeutic management of RA, including the long term benefit of early, aggressive treatment; the long term risks of not starting early therapy; the health risks of therapy, such as infections and malignancies; and other adverse events related to and its treatment d. The benefits of a collaborative team approach for the optimal management of the patient with RA Increase their planned frequency of use (as compared to their current frequency of use) of the following evidence based provisional diagnosis and patient care strategies: e. Use of a focused physical examination and functional assessment questions f. Use of appropriate laboratory tests g. Early referral to the rheumatologist when RA is suspected h. Patient monitoring strategies such as reviewing patient immunizations i. Coordinating patient care with a relevant specialist to ensure the best quality care Increased confidence in their ability to accurately diagnose and monitor patients with RA Accreditation/Designation: The Chatham institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. Chatham designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. It is the policy of Chatham to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All faculty, planners, and managers who affect the content of medical education activities sponsored by Chatham are required to disclose to the audience any real or apparent conflict of interest related to the activity. faculty, planners, and managers not complying with the disclosure policy will not be permitted to participate in this activity. Participants will receive disclosure information in writing at the educational activity. Commercial Support: This program is supported by educational grants from Abbott Laboratories, Bristol Myers Squibb, and Wyeth Pharmaceuticals.

7 Breakfast Symposium Saturday, February 9, :15 AM 7:45 AM Evidence Based Treatment Plans for the Management of Patients with Diabetes and Dyslipidemia Abhimanyu Garg, MD Professor of Internal Medicine Chief Division of Nutrition and Metabolic Diseases University of Texas Southwestern Medical Center Dallas, TX Eliot A. Brinton, MD Director, Metabolism Section, Cardiovascular Genetics Research Associate Professor, Attending Physician University of Utah School of Medicine Salt Lake City, UT List at least three ramifications of inadequate management of dyslipidemia and hyperglycemia in patient with type 2 diabetes and outline at least two clinician barriers to effective management of dyslipidemia and hyperglycemia in patient with type 2 diabetes Outline the physiologic mechanisms for metabolism of lipids and glucose and understand the indications for implementing pharmacologic agents to help achieve target goals in diabetic patients Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from M C Communications, LLC.

8 Lunch Symposium Saturday, February 9, :00 PM 1:30 PM Understanding Asthma: A Chronic Inflammatory Disease of the Large and Small Airways James P. Kemp, MD Clinical Professor of Pediatrics Division of Immunology and Allergy University of California, San Diego School of Medicine San Diego, CA Understand the inflammatory processes that occur in both the large and small airways and the implications for treatment Highlight key points of the updated guidelines and the clinical considerations arising from the switch from chlorofluorocarbon (CFC) to hydrofluoroalkane (HFA) inhalers Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from Teva Specialty Pharmaceuticals LLC.

9 Lunch Symposium Saturday, February 9, :00 PM 1:30 PM Applying Strategies for Cardiometabolic Disease Management: A Guide for the Primary Care Practitioner Steven M. Haffner, MD,MPH Professor of Internal Medicine Department of Medicine The University of Texas Health Science Center at San Antonio San Antonio, TX Frank Lavernia, MD North Broward Hospital District Private Practice Coconut Creek, FL Sergio Fazio, MD,PhD Professor of Medicine and Pathology Vanderbilt University School of Medicine Nashville, TN Describe the interrelated cardiovascular and metabolic risk factors that constitute the cardiometabolic syndrome and consider their impact on cardiovascular morbidity and mortality Evaluate current and emerging treatment strategies for early and aggressive management of type 2 diabetes and mixed dyslipidemia Review the mechanisms underlying the antiatherogenic properties of HDL and describe the rationale for HDL based therapeutics for the reduction of residual cardiovascular risk Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from Merck & Co., Inc.

10 Dinner Symposium Saturday, February 9, :45 PM 7:45 PM Advances in Opioid Analgesia: Evolving Strategies for Patient Management Eric Chevlen, MD Assistant Professor of Internal Medicine College of Medicine Northeastern Ohio Universities Rootstown, OH Comprehensive Cancer Care of Meadville Meadville Medical Center Meadville, PA Assess the risk level of those chronic pain patients most likely to benefit from opioid therapy Identify appropriate opioid analgesic agent(s), based on safety and efficacy data, and patient presentation Use appropriate documentation to meet medico legal requirements to support opioid prescribing Accreditation Statement: Professional Postgraduate Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: Professional Postgraduate Services designates this activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This activity is supported by an educational grant from Endo Pharmaceuticals, Inc.

11 Dinner Symposium Saturday, February 9, :45 PM 7:45 PM Looking Beyond Oral Agents: What to Do When Oral Therapies No Longer Maintain Treatment Goals in Type 2 Diabetes John S. Buse, MD,PhD,CDE,FACE Professor of Medicine Chief, Division of Endocrinology University of North Carolina School of Medicine Chapel Hill, NC Michael E. Cobble, MD Director, Canyons Medical Center Sandy, UT Ellie Strock, APRN,CDE Adult Nurse Practitioner Director Director, International Programs Education Park Nicollet Institute Minneapolis, MN Communicate the appropriate glucose goals for A1C, FPG and PPG to patients to enhance their understanding and adherence to diabetes therapy Outline a patient driven treatment algorithm for insulin therapy to allow patients to safely titrate to achieve A1C goals. Discuss the role of incretin based therapy in the management of type 2 diabetes patients who are not in adequate glycemic control on oral agents Accreditation Statement: Pri-Med institute is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians. Designation Statement: Pri-Med institute designates this educational activity for a maximum of 2.0 AMA PRA Category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. Commercial Support: This program is supported by an educational grant from Novo Nordisk Inc.

12 Industry-Supported Symposia Held during mealtime breaks during the Conference & Exhibition Attendance at Symposia sessions is limited Tickets are required for admission Registration for industry-supported Symposia is limited to physicians, physician assistants, and nurse practitioners currently engaged in patient care. Session information is subject to change *American with Disabilities Statement: In accordance with the Americans with Disabilities Act, Pri-Med institute seeks to make this conference accessible to all. If you have a need which might require special accommodations, please call 877-4PRI-MED or support@pri-med.com three weeks prior to the meeting M C Communications LLC. All rights reserved. Pri-Med is a registered trademark and Knowledge that touches patients is a trademark of M/C Communications, LLC. All other trademarks are the property of their respective owners PRI-MED ( )